These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8395108)

  • 1. Cytomegalovirus disease after liver transplantation: diagnostics and therapy.
    Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.
    Lautenschlager I; Höckerstedt K; Salmela K
    Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayr T; Prenner G; Hipmair G; Grasser B; Freigassner M
    J Heart Lung Transplant; 1996 Mar; 15(3):314-5. PubMed ID: 8777216
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for an immunosuppressive activity of ganciclovir.
    Scholz D; Arndt R; Meyer T
    Transplant Proc; 1994 Dec; 26(6):3253-4. PubMed ID: 7998132
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring for cytomegalovirus after organ transplantation: a clinical perspective.
    The TH; van den Berg AP; van Son WJ; Klompmaker IJ; Harmsen MC; van der Giessen M; Slooff MJ
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):5-9. PubMed ID: 8212306
    [No Abstract]   [Full Text] [Related]  

  • 6. [Identification of DNA of cytomegalovirus, its antibodies and viral antigens in patients after organ transplantation].
    Dolgikh MS; Vediakov AM; Feoktistova EIu; Adueva SM; Makarova NE; Kushch AA; Pustovoĭt B
    Biull Eksp Biol Med; 1999 May; 127(5):560-3. PubMed ID: 10399583
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of CMV-DNA in peripheral blood leukocytes of liver transplant patients after ganciclovir treatment.
    Loginov R; Höckerstedt K; Lautenschlager I
    Arch Virol; 2003 Jul; 148(7):1269-74. PubMed ID: 12827460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe cytomegalovirus ureteritis in a renal allograft recipient with negative CMV monitoring.
    Vaessen C; Kamar N; Mehrenberger M; Mazerolles C; Mengelle C; Rischmann P; Rostaing L; Malavaud B
    Nephrol Dial Transplant; 2005 Jan; 20(1):227-30. PubMed ID: 15632357
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and therapy of cytomegalovirus disease after liver transplantation.
    Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
    Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G
    Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for development of disease and should PCR be used to guide antiviral therapy?
    Abecassis MM; Koffron AJ; Buckingham M; Kaufman DB; Fryer JP; Stuart J; Stuart FP
    Transplant Proc; 1997; 29(1-2):800-1. PubMed ID: 9123532
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine).
    de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus surveillance following liver transplantation: does it allow presymptomatic diagnosis of cytomegalovirus disease?
    Umana JP; Mutimer DJ; Shaw JC; McLeish PJ; Buchan A; Martin B; Neuberger JM; Elias E; McMaster P
    Transplant Proc; 1992 Dec; 24(6):2643-5. PubMed ID: 1334593
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus infections and liver transplantation: an overview.
    Balfour HH; Heussner RC
    Transplant Proc; 1993 Apr; 25(2):2012-3. PubMed ID: 8385830
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis, treatment, and prophylaxis for cytomegalovirus disease following allogeneic stem cell transplantation].
    Gondo H
    Rinsho Ketsueki; 2003 Dec; 44(12):1154-60. PubMed ID: 14978931
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+) T-cell dynamics in primary cytomegalovirus infection.
    Rentenaar RJ; Gamadia LE; van der Hoek N; van Diepen FN; Boom R; Weel JF; van Lier RA; ten Berge IJ
    Transplant Proc; 2001 May; 33(3):2313-4. PubMed ID: 11377542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.